TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma.

Jason R Westin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.